Msd Wellcome Trust Hilleman Laboratories Private Limited
The wind-down at a glance. Follow the recorded outcome, financials and people behind this company.
What did the wind-down return?
Reported financials Rs crore, shown in lakh below Rs 1 crore
Where the money went
Reported amountsCreditor dues are not reported, so the payout cannot be assessed against them.
All financial figures & reading notes
| Realisation of assets | Not reported |
|---|---|
| Amount due to creditors | Not reported |
| Amount paid to creditors | Not reported |
| Liquidation expenses | Not reported |
| Surplus to members | Not reported |
"Not reported" means no figure is available. A reported zero is shown as zero. Registry capital further down the page is separate from liquidation proceeds, and so are any figures read from the NCLT order.
Where this wind-down sits
against every completed s.59 on the register185 days slower than the median of 618 days across 1,597 completed wind-downs
72% of completed wind-downs returned a surplus to members
This is a voluntary liquidation under IBC Section 59 — a solvent company choosing to wind up. Creditors are paid in full and costs met before any surplus returns to members; there is no haircut and no acquirer. Read assets realised, creditor payments, expenses and members' surplus separately.
The NCLT order
Read from the document itself
- Bench
- NEW DELHI COURT-IV
- Case number
- IB/316/ND/2025
- Order date
- 1 Jun 2026
Why the company wound up
In the order's own words
The Company struggled to build a profitable business model. The operations did not attain the financial viability required for long-term continuation.
- What it was set up to do
- research and development of affordable vaccines and related products for the prevention and or/treatment of infectious diseases in developing world
- What it was doing by the end
- The Company struggled to build a profitable business model. The operations did not attain the financial viability required for long-term continuation. As a result, the Company ceased active business operations a few years ago.
The wind-down, stage by stage
8 dated stages
- 15 Mar 2024 Declaration of solvency
- 20 Mar 2024 Liquidation commenced
- 19 Apr 2024 Last date for creditors to claim
- 2 May 2024 Preliminary report
- 22 May 2025 Final report
- 25 Jun 2025 Final report filed with the ROC
- 1 Jun 2026 NCLT order
- 1 Jun 2026 Dissolved
Green marks a date from the IBBI register; blue marks a date read from an NCLT order.
The company behind the record
Identity, registration and capital
- MCA status
- Under Liquidation
- Company class
- Private
- Category
- Company limited by shares
- Sub-category
- Non-government company
- Listing
- Unlisted
- State
- Delhi
- ROC
- ROC Delhi
- Industry
- Community, personal and Social Services
- PIN
- 110014
- Incorporated
- 13 Aug 2009order says 13 Aug 2019
- Authorised capital
- Rs 85.00 Crorder says Rs 850.00 Cr
- Paid-up capital
- Rs 81.38 Cr
- CIN
- U73100DL2009PTC193159
- Registered office
- D-15, Ground Floor Jangpura Extension,NEW DELHI,Delhi,110014-India
Directors named in the order
Chand Berry · Gerd Werner Zettlmeissl
Shareholding as the order states it
| Member | Shares | % |
|---|---|---|
| MSD Laboratories India LLC, USA | 4,06,92,405 | 50% |
| The Wellcome Trust Limited, UK | 4,06,92,405 | 50% |
The money, as the order printed it
Rs as stated in the document — not the crore figures above
What the company held
The Corporate Person did not possess any tangible or immovable assets. The only asset held by the Corporate Person was the bank balance available in its current account.
Creditors and claims
As the order records them
No financial creditor submitted any claims post the public announcement. Some claims were received from operational creditors, and all such liabilities have been settled accordingly and at this time no such liability exists.
Creditor approval
The creditors representing at least two-thirds in value of the debt of the Corporate Person approved the special resolutions passed in the EGM to initiate voluntary liquidation.
Litigation and delays
The frictions the order records
Litigation
No litigation or legal proceeding pending against the Corporate Person before any judicial, quasi-judicial or arbitral authority as on date of filing application, excluding pending/withdrawn tax/EPFO assessment matters and historical matters discussed.
Figures come from IBBI, NCLT, MCA and other official sources. Methodology · Report an error
See other companies in the voluntary liquidation register.